The Lundquist Institute holds both U.S. and international patents for this humanized antibody and has granted Vitalex, a Lundquist spin-off company, the commercial rights to advance this therapeutic ...

A new study offers hope in the fight against flesh-eating fungus infections. Researchers have discovered a promising antibody ...

Early tests suggest that an antibody-based therapy is safe, with no harmful effects on healthy cells, suggesting that it ...

Mucormycosis, a fungus infection caused by Mucorales, has a high mortality rates in those with weakened immune systems and ...

A deadly "flesh-eating" fungus is spreading rapidly in the US, posing a serious threat to people with weakened immune systems ...

Advt Ashraf Ibrahim, PhD, an investigator at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center ... and considered a medical emergency that needs immediate attention ...